pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
ATSN-201
Unspecified Ophthalmological Disorders
Atsena Therapeutics Inc
0
catalysts
Preclinical
ATX-101
T-Cell Lymphomas
Abcon Therapeutics Inc
0
catalysts
Phase 2
ATX-295
Ovarian Cancer
Accent Therapeutics Inc
0
catalysts
Phase 1
AU-409
Bile Duct Cancer (Cholangiocarcinoma)
← prev
page 58 of 231
next →
131
Pain
89
Neurology
1
Auransa Inc
0
catalysts
Phase 1
AUG-801
Congenital Disorder of Glycosylation
AUG Therapeutics LLC
0
catalysts
AUGMENTIN ES-600
AUGMENTIN ES-600 (AMOXICILLIN AND CLAVULANATE POTASSIUM)
US ANTIBIOTICS
0
catalysts
Preclinical
AUM-302
Neuroblastoma
AUM Biosciences Pte Ltd
0
catalysts
Phase 1
AUR-200
Systemic Lupus Erythematosus
$AUPH
Aurinia Pharmaceuticals Inc.
0
catalysts
Phase 1
AUT-00201
Myoclonic Seizure
Autifony Therapeutics Ltd
0
catalysts
Phase 1
AUT-00206
Fragile X Syndrome
Autifony Therapeutics Ltd
0
catalysts
Phase 2
AUTO-3
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
$AUTL
Autolus Therapeutics plc
0
catalysts
Phase 1
AUTX-703
Myelodysplastic Syndrome (Preleukemia)
Auron Therapeutics Inc
0
catalysts
Phase 2
AV-0328
Streptococcal Pneumonia
Alopexx Inc
0
catalysts
Phase 2
AV-1
Dengue Fever
Glutamate [NMDA] receptor
AbViro LLC
0
catalysts
Phase 2
AV-101
Major Depressive Disorder
Glutamate [NMDA] receptor
$VTGN
Vistagen Therapeutics, Inc.
0
catalysts
Phase 1
AV-1959D
Alzheimer's Disease
Nuravax Inc
0
catalysts
Phase 1
AV-203
Bladder Cancer
Receptor tyrosine-protein kinase erbB-3
AVEO Pharmaceuticals Inc
0
catalysts
Preclinical
AVA-2206
Cystinuria
Averoa SAS
0
catalysts
Phase 1
AVA-6103
Adenocarcinoma Of The Gastroesophageal Junction
Avacta Life Sciences Ltd
0
catalysts
Phase 2
AVB-101
Frontotemporal Dementia (Pick Disease)
AviadoBio Ltd
0
catalysts
Phase 2
AVB-114
Anal Fistula
Avobis Bio LLC
0
catalysts
Phase 2
AVC-203
Diffuse Large B-Cell Lymphoma
AvenCell Therapeutics Inc
0
catalysts
Phase 3
AVD-104
Dry (Atrophic) Macular Degeneration
Aviceda Therapeutics Inc
0
catalysts
Preclinical
AVG-002
Unspecified Respiratory Disorders
AlveoGene Ltd
0
catalysts
Phase 2
AVGBM-1
Glioblastoma Multiforme (GBM)
AiVita Biomedical Inc
0
catalysts
AVMAPKI FAKZYNJA CO-PACK
AVMAPKI FAKZYNJA CO-PACK (AVUTOMETINIB POTASSIUM AND DEFACTINIB HYDROCHLORIDE)
VERASTEM INC
0
catalysts
Phase 3
AVMEL-1
Melanoma
AiVita Biomedical Inc
0
catalysts
Phase 2
AVRRD-04
Cystinosis
$NVS
NOVARTIS AG
0
catalysts
AVSOLA
AVSOLA (INFLIXIMAB-AXXQ)
$AMGN
AMGEN INC
0
catalysts
Phase 2
AVT-001
Type 1 Diabetes (Juvenile Diabetes)
Avotres Inc
0
catalysts
